Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A localized, clonal (malignant) plasma cell infiltrate in the bone, without peripheral blood involvement. The most commonly affected bones are the vertebrae, ribs, skull, pelvis and femur. X-rays examination reveals a solitary lytic lesion.
Biomarker and diagnostic research for solitary osseous plasmacytoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy, other interventions, gene therapy, and procedural interventions. Research is primarily sponsored by academic and government institutions.
18 publications have been identified in PubMed for solitary osseous plasmacytoma. Research spans Case Report / Case Series (53%), Epidemiology / Natural History (18%), and Diagnostic / Biomarker (12%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:02 PM UTC
Disease patterns and progression | 3 | 18% |
Testing and diagnosis research | 2 | 12% |
Research summaries | 2 | 12% |
Laboratory research | 1 | 6% |
Saba L (2026). [PMID: 41879814](https://pubmed.ncbi.nlm.nih.gov/41879814/). *Am J Clin Oncol*. [Epidemiology / Natural History]
Choudhary NK (2026). [PMID: 41700227](https://pubmed.ncbi.nlm.nih.gov/41700227/). *Cureus*. [Case Report / Case Series]
Gupta R (2026). [PMID: 41554620](https://pubmed.ncbi.nlm.nih.gov/41554620/). *BMJ case reports*. [Case Report / Case Series]
Wu Q (2025). [PMID: 40223020](https://pubmed.ncbi.nlm.nih.gov/40223020/). *Annals of hematology*. [Basic Science / Preclinical]
Welsh CT (2025). [PMID: 39878086](https://pubmed.ncbi.nlm.nih.gov/39878086/). *Diagnostic cytopathology*. [Case Report / Case Series]
Avula VNPR (2025). [PMID: 41170273](https://pubmed.ncbi.nlm.nih.gov/41170273/). *Cureus*. [Case Report / Case Series]
Miladinovic V (2025). [PMID: 38967687](https://pubmed.ncbi.nlm.nih.gov/38967687/). *Skeletal radiology*. [Diagnostic / Biomarker]
Woods K (2025). [PMID: 41154352](https://pubmed.ncbi.nlm.nih.gov/41154352/). *Cancers*. [Epidemiology / Natural History]
Wen J (2025). [PMID: 41327780](https://pubmed.ncbi.nlm.nih.gov/41327780/). *The American journal of case reports*. [Case Report / Case Series]
Alabdulaaly L (2025). [PMID: 40722107](https://pubmed.ncbi.nlm.nih.gov/40722107/). *Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology*. [Review / Meta-Analysis]
AI-curated news mentioning solitary osseous plasmacytoma
Updated Jul 22, 2026
The International Myeloma Working Group has released updated recommendations for diagnosing and managing solitary plasmacytomas. These guidelines aim to standardize care and improve outcomes for patients with this rare condition.